Sirtuin 5 levels are limiting in preserving cardiac function and suppressing fibrosis in response to pressure

Angela H Guo1,2, Rachael Baliira1, Mary E Skinner1

  • 1Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.

Scientific Reports
|July 19, 2022
PubMed

Insights

Sirtuin 5 (SIRT5) overexpression protected mice from heart failure induced by pressure overload. SIRT5 plays a key role in preserving cardiac function during stress.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Metabolic Regulation in Heart Disease

Background:

  • Heart failure (HF) involves impaired cardiac function due to hypertrophy, fibrosis, and reduced contractility.
  • Sirtuin 5 (SIRT5), a NAD+-dependent deacylase, is crucial for cellular metabolism and stress response.
  • Previous studies on SIRT5 in the heart used loss-of-function models, showing hypersensitivity to stress.

Purpose of the Study:

  • To investigate the role of SIRT5 in cardiac adaptation to chronic pressure overload.
  • To evaluate the protective effects of SIRT5 overexpression (SIRT5OE) against heart failure development.

Main Methods:

  • Generation of SIRT5 overexpressing (SIRT5OE) mice.
  • Induction of chronic pressure overload using transverse aortic constriction (TAC).
  • Assessment of cardiac function, including left ventricular dimensions and ejection fraction.
  • Transcriptomic analysis to identify molecular pathways regulated by SIRT5.

Main Results:

  • SIRT5OE mice showed protection against TAC-induced adverse cardiac remodeling and functional decline.
  • Overexpression of SIRT5 prevented left ventricular dilation and preserved ejection fraction.
  • Transcriptomic data indicated SIRT5 suppresses HF-associated metabolic shifts (glycolysis over fatty acid oxidation), immune activation, and fibrosis.

Conclusions:

  • SIRT5 overexpression confers protection against experimental heart failure induced by pressure overload.
  • SIRT5 acts as a critical regulator, mitigating key pathological pathways in the stressed heart.
  • SIRT5 is a limiting factor for preserving cardiac function under chronic stress conditions.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
501
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
790